Skip to main content
Molecule libraryReference fact sheet

SNAP-8

Why this molecule?

Can facial expression be addressed topically rather than by injection? That is the question behind the peptide family from which SNAP-8 comes.

Cosmetic research ~4 min readAlso known asAcetyl octapeptide-3Argireline®-8
  • Research Use Only
  • Molecule under study
  • Living document

View the corresponding reference in the shop

Research state
Current research state
Cosmetic research — used in topical formulations, with limited clinical data.
Current clinical phase
No registered pharmaceutical development.
Last update
21 July 2026 · Reference fact sheet v1.0
Living document
Updated regularly as research progresses.
01 · Reference points

What is SNAP-8?

SNAP-8 is a synthetic peptide composed of eight amino acids (INCI: acetyl octapeptide-3).

It belongs to the same peptide family as Argireline, with two additional amino acids intended to improve affinity for its target.

It is used in topical cosmetics and studied in skin research.

02 · Reference points

Names you may come across

This molecule is mainly designated under the following names in the literature.

SNAP-8

Most common cosmetic trade name.

Acetyl octapeptide-3

Official INCI name.

03 · Made simple

Understanding it simply

SNAP-8 draws on the mechanism of a well-known peptide.

1

A relative of Argireline

SNAP-8 follows the same rationale as Argireline, with a slightly longer sequence.

2

A topical mechanism

Its relevance lies in the superficial layers of the skin when applied locally.

3

A SNARE target

It is studied for its ability to modulate, in vitro, the SNARE complex involved in neurotransmitter release.

04 · Scientific honesty

What research shows today

Science advances step by step. We clearly distinguish what is firmly established from what remains under study.

Current state of knowledge
  • Mechanism derived from inhibition of the SNARE complex, well characterized in vitro. — established
  • Topical cosmetic use documented by formulators. — established
  • Evidence from controlled human clinical studies remains limited. — ongoing

Predominantly in vitro and topical cosmetic data; no dedicated large-scale clinical trials.

What the research shows

  • Structure and rationale for its mechanism of action well documented in the cosmetic literature.
  • Topical formulation widely used in skincare products.

What still remains to be studied

  • Large-scale independent clinical trials remain few in number.
  • Further objective comparison of SNAP-8, Argireline, and other cosmetic peptides is needed.
05 · Three reading levels

What we know today

Not all information carries the same weight of evidence. We therefore present it across three clearly distinct levels, from the most solid to the most indicative.

What scientific publications show

Scientific evidence
  • In vitro studies show inhibition of the SNARE complex at concentrations relevant to topical formulations.
  • Controlled human clinical data remain limited.

What some professionals report

Documented
  • Cosmetic formulators position SNAP-8 as a topical alternative within the category of peptides targeting expression-related signs of aging.

What the community reports

Field observations
  • Community feedback describes gradual visual improvement with regular topical use.
  • These individual observations do not replace controlled clinical data.

The evidence base remains emerging: SNAP-8 is a documented cosmetic active ingredient, but it has been little studied outside the field of cosmetic science.

06 · The mechanism

How does SNAP-8 work?

SNAP-8 is studied for its ability to modulate neurotransmitter release at cutaneous nerve endings in vitro.

SNARE complex
Protein assembly involved in vesicle fusion and neurotransmitter release.
SNAP-25
Protein in the SNARE complex, a target studied in research on neuromuscular signaling.
Skin (topical)
Route of application studied in the cosmetic literature.

These mechanisms are documented in vitro and do not imply any effect equivalent to that of an injectable toxin.

07 · The scientific journey

Clinical trials timeline

A molecule under study progresses step by step. Here, simply, is where the research currently stands.

DiscoveryPreclinicalPhase IPhase IIPhase IIIRegulatory
  1. Discovery· 2000sCompleted

    Development of the Argireline family

    Lipotec introduces Argireline (acetyl hexapeptide-8), then develops SNAP-8 as a further development.

  2. Cosmetic· 2010sCompleted

    Wider adoption in topical formulations

    SNAP-8 is incorporated into many anti-aging cosmetic formulations.

  3. Research· TodayOngoing

    Occasional publications

    Independent clinical studies remain limited.

08 · Documented proof

Available analyses

No analytical document has been published for this molecule to date.

Open the analysis library
09 · Reference points

Frequently asked questions

Is SNAP-8 equivalent to Botox?

No. SNAP-8 is a topical peptide whose mechanism draws on the same biological target (SNAP-25), but whose effect cannot be compared with that of an injectable toxin.

Can SNAP-8 be used by injection?

No. SNAP-8 is studied as a topical cosmetic active ingredient. No injectable use has been validated.

11 · The vocabulary

Glossary

SNARE
Protein complex involved in vesicle fusion and neurotransmitter release.
SNAP-25
Protein in the SNARE complex, a target of research on neuromuscular signaling.
INCI
The international naming system for cosmetic ingredients.
The PHL ecosystem

Continue your discovery

Read next

Sheets that are thematically close. These links serve reading and discovery — they suggest no combined use.

Reference fact sheet — version 1.0, updated on 21 July 2026. The full regulatory and scientific framework is gathered in the “Important information” box at the top of the fact sheet.

Explore the fundamentals related to this goal

This general content is independent of the molecule and is neither a use strategy nor a protocol.